DexCom Balance Sheet Health
Financial Health criteria checks 6/6
DexCom has a total shareholder equity of $2.0B and total debt of $2.4B, which brings its debt-to-equity ratio to 123.3%. Its total assets and total liabilities are $6.4B and $4.4B respectively. DexCom's EBIT is $628.0M making its interest coverage ratio -5.3. It has cash and short-term investments of $2.5B.
Key information
123.3%
Debt to equity ratio
US$2.44b
Debt
| Interest coverage ratio | -5.3x |
| Cash | US$2.49b |
| Equity | US$1.98b |
| Total liabilities | US$4.37b |
| Total assets | US$6.35b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0A4M's short term assets ($4.3B) exceed its short term liabilities ($1.7B).
Long Term Liabilities: 0A4M's short term assets ($4.3B) exceed its long term liabilities ($2.6B).
Debt to Equity History and Analysis
Debt Level: 0A4M has more cash than its total debt.
Reducing Debt: 0A4M's debt to equity ratio has reduced from 137% to 123.3% over the past 5 years.
Debt Coverage: 0A4M's debt is well covered by operating cash flow (33.7%).
Interest Coverage: 0A4M earns more interest than it pays, so coverage of interest payments is not a concern.